Subject: Liver Toxicity of Acetaminphen Ignored by FDA

[Guest guest]

Liver Toxicity of Acetaminphen Ignored by FDA

JoAnn Guest

Aug 04, 2005 13:04 PDT

 

 

 

FDA CHASES ALLEGED CASES OF LIVER TOXICITY FROM KAVA KAVA HERB WHILE

70,000 CASES OF LIVER TOXICITY FROM ACETAMINOPHEN ARE IGNORED

 

SAN DIMAS, CA- Based upon reports from Europe that the

stressrelieving

herbal product kava kava (Peper methysticum) is possibly associated

with

liver problems, the US Food & Drug Administration has announced it

is

seeking help from the public and health professionals in determining

if

there are any cases of liver toxicity emanating from the use of kava

kava.

 

Yet the FDA continues to ignore the 70,000 confirmed cases of liver

toxicity that occur annually from acetaminophen pain relievers.

 

The American Poison Control Centers count about 70-100 deaths per

year

from acetaminophen poisoning. More than 8 billion acetaminophen

pills

are sold annually.

 

Health authorities in Switzerland and Germany have prohibited the

sale

of kava kava based upon reports of adverse effects. About 25 cases

of

liver toxicity have been reported throughout Europe. Merck

permenently

discontinued sale of its two kava products in Germany in December.

The

two kava products generated over $220 million of sales annually for

Merck.

 

But the herb was used in conjunction with prescription

pharmaceuticals

so it is dfficult to conclude that kava is the sole cause of the

liver

toxicity.

 

The US FDA issued their letter in December with a hotline number for

consumers or health authorities to call the FDA's MedWatch program.

 

FDA Ignores Antidote

 

Additionally, the FDA is also ignoring a plea by a doctor to add the

antidote to acetaminophen poisoning to over-the-counter tablets

which

would avoid liver toxicity altogether.

 

James P. Andrus of the Department of Pediatrics at Stanford

University

Medical School has called upon the FDA and manufacturers of

acetaminophen to include N acetyl-cysteine (NAC) in pain relief

pills to

prevent liver toxicity.

 

[british Medical Journal, Vol. 323, Sept. 15, 2001] N acetyl

cysteine is

commonly used to treat acetaminophen toxicity and is an over-the-

counter

sulfur-bearing food supplement. [Postgraduate Medicine, Vol. 105,

April

1999]

 

Acetaminophen overdose results in more calls to poison control

centers

in the United States than overdose with any other pharmacologic

substance.

 

[Am J Health System Pharm, Volume 56, June 1999] The American Liver

Foundation reports that 35% of cases of severe liver failure are

caused

by acetaminophen poisoning which may require organ transplantation.

 

[uSA TODAY, August 13, 2001]

 

Toxicity occurs in the liver when levels of glutathione, an

antioxidant

that is concentrated in the liver, are depleted by acetaminophen.

 

Dr. Andrus says the problem is best treated by prevention and

suggests

200 milligrams of NAC be added to a 500-milligram acetaminophen

tablet.

 

Acetaminophen also increases the relative risk of kidney failure by

40

percent when taking as little as two acetaminophen tablets per week.

 

The risk of kidney failure increases 200 percent among individuals

who

take 1000 or more acetaminophen pills over a lifetime. [N Eng J Med,

Volume 331, Dec. 22, 1994]

 

Tylenol (McNeil Labs, J & J) is the most widely known brand of

acetaminophen. ####

 

Written By: Bill Sardi

_________________

JoAnn Guest

mrsjo-

www.geocities.com/mrsjoguest/Genes